| Product Name: | Deflazacort |
| Synonyms: | (11β,16β)-11,21-Dihydroxy-2′-methyl-5’H-pregna-1,4-dieno[17,16-d][1,4]oxazolin-6-one 21-acetate |
| CAS No: | 14484-47-0 |
| Chemical Formula: | C25H31NO6 |
| Grade: | IH |
| Appearance: | Crystalline powder |
| Molar Mass: | 441.52 g/mol |
| Solubility: | Slightly soluble in water, soluble in methanol, ethanol, and chloroform |
Description
Chemignition is a leading manufacturer and exporter of Deflazacort Active Pharmaceutical Ingredients (API) worldwide. The company adheres to strict Quality Management Systems (QMS) to ensure compliance with Good Manufacturing Practices (cGMPs). This commitment guarantees that Chemignition produces Deflazacort of the highest quality and efficacy.
Healthcare providers prescribe Deflazacort as a corticosteroid medication to reduce inflammation and suppress the immune system. They commonly use it to treat various conditions, including autoimmune diseases, allergic reactions, muscular dystrophy, asthma, and skin disorders.
During the manufacturing of Active Pharmaceutical Ingredients (API) and specialty chemicals, Chemignition performs various processes, including dissolution, charcoalization, filtration, leaching, extraction, crystallization, and purification.
Manufacturers frequently use Deflazacort API in pharmaceutical products, such as tablets, liquid suspensions, and injections.
The U.S. Food and Drug Administration (FDA) first approved Deflazacort in 1989. It now holds recognition for its efficacy in treating various inflammatory and autoimmune conditions, particularly in pediatric patients with Duchenne muscular dystrophy.
Storage Conditions: Pack Deflazacort in a double polybag and keep it in a tightly closed HDPE container, stored at a temperature between 20°C and 25°C.